Inc., a company specializing in laboratory analytical instruments, has terminated a material definitive agreement with Cowen and Company, LLC. This termination, effective February 14, 2025, was ...

Bionano Genomics Inc. (NASDAQ:BNGO) stock has tumbled to a 52-week low, touching down at $4.9 as the company faces a challenging market environment. According to InvestingPro data, the stock's RSI ...

SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO)(the “Company”) today announced that it will effect a reverse stock split of its issued and outstanding common ...

Check the time stamp on this data. Updated AI-Generated Signals for Bionano Genomics Inc. (BNGO) available here: BNGO. Type a ...

SAN DIEGO, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced publication of a case study from the Shenzhen Maternity and Child Healthcare Hospital ...

Such adjustments could be material. “2024 was a year of substantial change for Bionano in which we focused on two key objectives: (i) restructuring the company to reduce costs significantly to ...

Gene sequencing company Bionano Genomics (NASDAQ:BNGO) traded ~8% lower in the premarket on Thursday after announcing a 1-for-60 reverse stock split that will take effect on Friday at 5 p.m. In a ...

Bionano Genomics, Inc. announced a settlement agreement that modifies its existing senior secured convertible debentures due in May 2024. The amendment defers the December 2024 amortization ...

The latest update is out from BioNano Genomics ( (BNGO)). Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with ...